A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus-Reference-Cited by-同舟云学术

A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

Published:1997-09-18 Issue:12 Volume:337 Page:801-808
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Whalen Christopher C.,Johnson John L.,Okwera Alphonse,Hom David L.,Huebner Robin,Mugyenyi Peter,Mugerwa Roy D.,Ellner Jerrold J.,Nsubuga Peter,Vjecha Michael,Myanja Harriet,Kityo Cissy,Loughlin Anita,Milberg John,Pekovic Vukosava

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199709183371201

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention;Clinical Infectious Diseases;2024-04-03

2. The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV;The International Journal of Tuberculosis and Lung Disease;2024-01-01

3. Geographical, social, and political contexts of tuberculosis control and intervention, as reported by mid-level health managers in Uganda: ‘The activity around town’;Social Science & Medicine;2023-12

4. Chapitre 6: Le traitement préventif de la tuberculose chez les adultes;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-11-02

5. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis;The Lancet Respiratory Medicine;2023-09